-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$31.75100.44% Upside
Tyra Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Tyra Biosciences, Inc.?
Tyra Biosciences, Inc. has been rated by research analysts at H.C. Wainwright, Bank of America Securities, Oppenheimer, Raymond James in the past 90 days.